Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $19,460 - $22,700
202 Added 7.35%
2,951 $303,000
Q1 2023

May 12, 2023

BUY
$107.32 - $113.5 $27,366 - $28,942
255 Added 10.22%
2,749 $300,000
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $155,600 - $283,817
2,494 New
2,494 $283,000
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $152,448 - $223,411
-1,920 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $165,926 - $210,835
1,920 New
1,920 $202,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Fund Management At Engine No. 1 LLC Portfolio

Follow Fund Management At Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.